These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34170380)

  • 1. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
    Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
    Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
    BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study.
    Li M; Zeng Y; Li Y; Jia D; Chen S; Wang J
    BMC Pulm Med; 2021 Dec; 21(1):402. PubMed ID: 34872535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic pleural effusions.
    Lau MS; Pien FD
    Hawaii Med J; 1990 Jun; 49(6):206-7. PubMed ID: 2397989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
    Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
    PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic utility of pleural fluid eosinophilia].
    Nasiłowski J; Krenke R; Przybyłowski T; Abouchaz B; Dmowska-Sobstyl B; Droszcz W; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):10-5. PubMed ID: 17175969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
    Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
    Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
    Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
    J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and aetiology of eosinophilic pleural effusion.
    Krenke R; Nasilowski J; Korczynski P; Gorska K; Przybylowski T; Chazan R; Light RW
    Eur Respir J; 2009 Nov; 34(5):1111-7. PubMed ID: 19386682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
    Tian T; Li J; Hu W; Sun C; Zhou J
    J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
    Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
    Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
    Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
    Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic pleural effusion: incidence, etiology and prognostic significance.
    Ferreiro L; San José E; González-Barcala FJ; Alvarez-Dobaño JM; Golpe A; Gude F; Anchorena C; Pereyra MF; Zamarrón C; Valdés L
    Arch Bronconeumol; 2011 Oct; 47(10):504-9. PubMed ID: 21831499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
    Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
    Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.